real-world outcomes of hepatitis C treatment in thai patients

被引：0
|
作者：
Thanak, Pongpan [1 ]
Kitiyakara, Taya [1 ]
Intaraprasong, Pongphob [1 ]
Sobhonslidsuk, Abhasnee [1 ]
Achalanan, Narin [1 ]
Kamalaporn, Patarapong [1 ]
Kositchaiwat, Chomsri [1 ]
机构：
[1] Mahidol Univ, Ramathibodi Hosp, Dept Med, Bangkok 10700, Thailand
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2012年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：247 / 247
页数：1
相关论文
共 50 条
  • [41] Sofosbuvir/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan
    Yu-Ting Huang
    Yung-Yu Hsieh
    Wei-Ming Chen
    Shui-Yi Tung
    Kuo-Liang Wei
    Chen-Heng Shen
    Kao-Chi Chang
    Chung-Kuang Lu
    Chih-Wei Yen
    Sheng-Nan Lu
    Chao-Hung Hung
    Te-Sheng Chang
    BMC Gastroenterology, 21
  • [42] Real-world results of direct-acting antivirals use for the treatment of chronic hepatitis C in old patients
    Mohamed El Kassas
    Reem El Sheemy
    Mohamed Alboraie
    Mohamed El Badry
    Mohamed Naguib Wifi
    Naglaa Youssef
    Sameera Ezzat
    Marwa Tahoon
    Lobna Abdelsalam
    Sara M. Abdelhakam
    Zainab Ali-Eldin
    European Geriatric Medicine, 2019, 10 : 295 - 302
  • [43] Real-world results of direct-acting antivirals use for the treatment of chronic hepatitis C in old patients
    El Kassas, Mohamed
    El Sheemy, Reem
    Alboraie, Mohamed
    El Badry, Mohamed
    Wifi, Mohamed Naguib
    Youssef, Naglaa
    Ezzat, Sameera
    Tahoon, Marwa
    Abdelsalam, Lobna
    Abdelhakam, Sara M.
    Ali-Eldin, Zainab
    EUROPEAN GERIATRIC MEDICINE, 2019, 10 (02) : 295 - 302
  • [44] Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study
    Fanpu Ji
    Wenjun Wang
    Shuangsuo Dang
    Shengbang Wang
    Burong Li
    Dan Bai
    Wenxue Zhao
    Hong Deng
    Changyin Tian
    Zongfang Li
    Infectious Agents and Cancer, 12
  • [45] Real-world effectiveness of ledipasvir/sofosbuvir 8 weeks chronic hepatitis C treatment
    Buggisch, Peter
    Wursthorn, Karsten
    Stoehr, Albrecht
    Gauthier, Aline
    Atanasov, Petar K.
    Petersen, Joerg
    HEPATOLOGY, 2015, 62 : 806A - 806A
  • [46] Outcomes of patients with chronic hepatitis C and hepatocellular carcinoma treated with direct-acting antivirals: Real-world experience
    Sriphoosanaphan, S.
    Ananchuensook, P.
    Siripon, N.
    Suksawatamnuay, S.
    Thaimai, P.
    Sittisomwong, S.
    Thanapirom, K.
    Komolmit, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 195 - 196
  • [47] Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study
    Ji, Fanpu
    Wang, Wenjun
    Dang, Shuangsuo
    Wang, Shengbang
    Li, Burong
    Bai, Dan
    Zhao, Wenxue
    Deng, Hong
    Tian, Changyin
    Li, Zongfang
    INFECTIOUS AGENTS AND CANCER, 2017, 12
  • [48] Real-world effectiveness of ledipasvir/sofosbuvir 8 weeks chronic hepatitis C treatment
    Buggisch, P.
    Wursthorn, K.
    Gauthier, A.
    Atanasov, P.
    Petersen, J.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 24 - 25
  • [49] Real-world effectiveness of sofosbuvir/velpatasvir for the treatment of hepatitis C virus in prison settings
    Rosati, Silvia
    Wong, Alexander
    Di Marco, Vito
    Perez-Hernandez, Paco
    Macedo, Guilherme
    Brixko, Christian
    Ranieri, Roberto
    Campanale, Francesca
    Bascia, Annalisa
    Fernandez-Rodriguez, Conrado
    de Ledinghen, Victor
    Maida, Ivana
    Teti, Elisabetta
    Mangia, Alessandra
    Vanstraelen, Kim
    Hernandez, Candido
    Mertens, Michael
    Ntalla, Ioanna
    Ramroth, Heribert
    Jimenez, Elena
    FUTURE VIROLOGY, 2022, 17 (07) : 419 - 428
  • [50] Hepatitis C (HCV) Treatment and SVR: The Gap Between Clinical Trials and the Real-World
    Tahir, Madiha
    Alvi, Fatima
    Alam, Imtiaz
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S125 - S125
12345